INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 263 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $8,400,680 | +60.5% | 206,000 | +37.3% | 1.04% | -5.3% |
| Q4 2022 | $5,233,500 | -25.2% | 150,000 | +20.0% | 1.10% | -19.2% |
| Q3 2022 | $6,995,000 | +61.8% | 125,000 | +49.7% | 1.36% | +52.9% |
| Q2 2022 | $4,322,000 | +18.9% | 83,495 | +67.0% | 0.89% | -6.0% |
| Q1 2022 | $3,634,000 | -38.5% | 50,000 | 0.0% | 0.95% | -42.2% |
| Q4 2021 | $5,912,000 | -11.9% | 50,000 | 0.0% | 1.64% | -15.1% |
| Q3 2021 | $6,708,000 | +38.1% | 50,000 | +66.7% | 1.93% | +44.2% |
| Q2 2021 | $4,857,000 | -64.4% | 30,000 | -82.4% | 1.34% | -65.7% |
| Q1 2021 | $13,643,000 | +318.0% | 170,000 | +183.3% | 3.90% | +301.4% |
| Q4 2020 | $3,264,000 | – | 60,000 | – | 0.97% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
| Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
| MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
| ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
| Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
| Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
| Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
| Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
| Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |